Stocks and Investing Stocks and Investing
Mon, June 14, 2021

Liana Moussatos Maintained (ASND) at Buy with Decreased Target to $189 on, Jun 14th, 2021


Published on 2024-10-27 16:58:30 - WOPRAI, Liana Moussatos
  Print publication without navigation


Liana Moussatos of Wedbush, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $219 to $189 on, Jun 14th, 2021.

Liana has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 1 agrees with Liana's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Tuesday, March 30th, 2021


These are the ratings of the 2 analyists that currently disagree with Liana


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $196 on, Tuesday, June 1st, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $178 on, Friday, May 28th, 2021
Contributing Sources